Daniel Hahn

Background

About Daniel Hahn

With over 20 years of experience in consulting, services sales, business management, and customer relationship management, I am a Consulting Services Regional Vice President at Salesforce, leading high-performance teams of account partners and engagement managers. I hold four Salesforce certifications, including Administrator, Sales Cloud, Service Cloud, and AI Associate, demonstrating my proficiency and knowledge in the Salesforce platform and its applications. My mission is to drive unparalleled performance in high-growth teams by hiring, enabling, managing, and mentoring motivated, dedicated, and authentic professionals. My teams succeed by defining territory and account strategies that collectively define and align transformational, business, functional and technical capabilities-focused solutions; aligning go-to-market and delivery vision; delivering differentiated customer, user, partner, and stakeholder experiences; achieving transformational results; and influencing C-suite customers. I have applied this approach in HLS, Telecom, Financial Services, Business Services and States & Local Government industry domains. Some of my recent achievements and recognition include Chairman's Club, 300% YOY portfolio growth, 230% attainment, and selling the largest ever HLS deal. A passion of mine - stemming from academics - is simplifying complex and emerging technologies, such as AI, into compelling and human-centered solutions. Outside of solution development in my consulting career, past examples of this passion include: 1) credit in Managerial Accounting texts for contributing to exercises applying data analysis techniques for cost-driver identification and scorecard development; 2) leading Fordham University seminars in quantitative supply chain management techniques; and 3) having a cover article published in Bio-Pharm International, a leading industry journal, focused on EDM Maturity and Life Cycle Management and delivery methodologies in regulated industries (e.g. Pharmaceuticals).